Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Nov 17, 2021 · 10-Q · 48 days after period end · 0001539497-21-001861
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$609.68K | -$202.04K | -$874.12K | -$47.52K |
| EPS Diluted | $0.00 | $0.00 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 17, 2021 · 48 d after period end
